OKUR OnKure Therapeutics, Inc.
Nasdaq · SEC CIK 1637715 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $5,632 8 sales by 2 insiders
- Filings on record
- 114 since 2021-07-09, latest 2026-09-23 16:54
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Leverone Jason A. | CFO | — | $4,379 |
| Saccomano Nicholas A | Pres, CEO, Dir | — | $1,253 |
| Manke Isaac | Dir | — | — |
| Mathers Edward T | Dir | — | — |
Transactions 57
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-23 16:54 | 2026-09-21 | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.97 | -87 | 11.2K | -0.8% | -$258.76 | |
| 2026-09-23 16:52 | 2026-09-21 | OKUR | Leverone Jason A. | CFO | S - Sale | $2.97 | -302 | 18.5K | -2% | -$898.21 | |
| 2026-06-24 19:29 | 2026-06-22 | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $4.40 | -86 | 11.2K | -0.8% | -$378.08 | |
| 2026-06-24 19:27 | 2026-06-22 | OKUR | Leverone Jason A. | CFO | S - Sale | $4.40 | -303 | 18.8K | -2% | -$1,332 | |
| 2026-03-24 | 2026-03-23 | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $4.16 | -86 | 7,333 | -1% | -$357.76 | |
| 2026-03-24 | 2026-03-23 | OKUR | Leverone Jason A. | CFO | S - Sale | $4.16 | -301 | 16.0K | -2% | -$1,252 | |
| 2026-01-02 | 2025-12-31 | OKUR | Mathers Edward T | Dir | A - Grant | $0.00 | +3,911 | 15.3K | +34% | $0 | |
| 2026-01-02 | 2025-12-31 | OKUR | Manke Isaac | Dir | A - Grant | $0.00 | +5,258 | 20.6K | +34% | $0 | |
| 2025-12-23 | 2025-12-22 | OKUR | Leverone Jason A. | CFO | S - Sale | $2.97 | -302 | 16.3K | -2% | -$896.94 | |
| 2025-12-23 | 2025-12-22 | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.97 | -87 | 7,419 | -1% | -$258.39 | |
| 2025-10-02 | 2025-09-30 | OKUR | Mathers Edward T | Dir | A - Grant | $0.00 | +4,125 | 11.4K | +57% | $0 | |
| 2025-10-02 | 2025-09-30 | OKUR | Manke Isaac | Dir | A - Grant | $0.00 | +5,545 | 15.3K | +57% | $0 | |
| 2025-09-24 | 2025-09-22 | OKUR | Leverone Jason A. | CFO | S - Sale | $2.62 | -303 | 12.6K | -2% | -$793.86 | |
| 2025-09-24 | 2025-09-22 | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.62 | -88 | 3,506 | -2% | -$230.56 | |
| 2025-07-02 | 2025-06-30 | OKUR | Manke Isaac | Dir | A - Grant | $0.00 | +6,311 | 9,780 | +182% | $0 | |
| 2025-07-02 | 2025-06-30 | OKUR | Mathers Edward T | Dir | A - Grant | $0.00 | +4,694 | 7,274 | +182% | $0 | |
| 2025-06-25 | 2025-06-23 | OKUR | Leverone Jason A. | CFO | S - Sale | $2.38 | -303 | 12.9K | -2% | -$721.14 | |
| 2025-06-25 | 2025-06-23 | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.38 | -88 | 3,594 | -2% | -$209.44 | |
| I | 2025-05-19 | 2025-05-15 | OKUR | Cormorant Private Healthcare Fund III LP | Former 10% Owner | S - Sale | $1.85 | -1.81M | 0 | -100% | -$3.35M |
| I | 2025-05-19 | 2025-05-15 | OKUR | ACORN CAPITAL ADVISORS GP, LLC | 10% | P - Purchase | $1.85 | +1.13M | 1.13M | New | +$2.09M |
| 2025-05-19 | 2025-05-15 | OKUR | ACORN CAPITAL ADVISORS GP, LLC | 10% | P - Purchase | $1.85 | +270.3K | 1.71M | +19% | +$500.0K | |
| I | 2025-05-14 | 2025-05-12 | OKUR | Cormorant Global Healthcare Master Fund, LP | 10% | S - Sale | $1.99 | -24.3K | 1.81M | -1% | -$48.4K |
| M | 2025-04-08 | 2025-04-04+ | OKUR | Leverone Jason A. | CFO | S - Sale | $2.94 | -3,122 | 13.2K | -19% | -$9,179 |
| M | 2025-04-08 | 2025-04-04+ | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | S - Sale | $2.94 | -874 | 4,198 | -17% | -$2,570 |
| 2025-04-02 | 2025-03-31 | OKUR | Mathers Edward T | Dir | A - Grant | $0.00 | +2,580 | 2,580 | New | $0 | |
| 2025-04-02 | 2025-03-31 | OKUR | Manke Isaac | Dir | A - Grant | $0.00 | +3,469 | 3,469 | New | $0 | |
| 2024-10-09 | 2024-10-07 | OKUR | Leonard Braden Michael | Former 10% owner of RPHM | J - Other | — | +102.1K | 102.1K | New | — | |
| I | 2024-10-09 | 2024-10-07 | OKUR | Leonard Braden Michael | Former 10% owner of RPHM | J - Other | — | +345.7K | 345.7K | New | — |
| DM | 2024-10-08 | 2024-10-04 | OKUR | Carruthers R Michael | Dir | A - Grant | — | +4,939 | 874 | New | — |
| D | 2024-10-08 | 2024-10-04 | OKUR | Saccomano Nicholas A | Pres, CEO, Dir | A - Grant | — | +4,556 | 4,556 | New | — |
| D | 2024-10-08 | 2024-10-04 | OKUR | Leverone Jason A. | CFO | A - Grant | — | +16.3K | 16.3K | New | — |
| MI | 2024-09-26 | 2024-09-24+ | OKUR | Leonard Braden Michael | 10% | P - Purchase | $1.47 | +98.3K | 3.46M | +3% | +$144.9K |
| MI | 2024-09-19 | 2024-09-17+ | OKUR | Leonard Braden Michael | 10% | P - Purchase | $1.36 | +56.1K | 3.36M | +2% | +$76.3K |
| MI | 2024-09-16 | 2024-09-12+ | OKUR | Leonard Braden Michael | 10% | P - Purchase | $1.35 | +358.9K | 2.98M | +14% | +$483.8K |
| MI | 2024-08-14 | 2024-08-13+ | OKUR | Leonard Braden Michael | 10% | P - Purchase | $1.40 | +271.8K | 2.94M | +10% | +$379.8K |
| MI | 2024-05-16 | 2024-05-14 | OKUR | Leonard Braden Michael | 10% | P - Purchase | $1.54 | +414.3K | 2.67M | +18% | +$639.6K |
| D | 2023-08-29 | 2023-08-28 | OKUR | Hall Ashley | Chief Development Off | S - Sale+OE | $6.28 | -15.6K | 39.6K | -28% | -$98.1K |
| D | 2023-08-29 | 2023-08-28 | OKUR | Hall Ashley | Chief Development Off | M - OptEx | $1.80 | +15.6K | 55.2K | +39% | +$28.1K |
| 2023-07-27 | 2023-07-26 | OKUR | GREY MICHAEL G | Executive COB, Dir | G - Gift | $0.00 | -50.0K | 0 | -100% | $0 | |
| 2023-06-23 | 2023-06-23 | OKUR | Novo Holdings A/S | 10% | S - Sale | $7.10 | -100.0K | 3.33M | -3% | -$710.0K | |
| I | 2023-05-10 | 2023-05-08 | OKUR | O'Donnell Niall | Dir | P - Purchase | $8.00 | +125.0K | 2.19M | +6% | +$1.00M |
| D | 2022-12-13 | 2022-08-12 | OKUR | Dorenbaum Alejandro | Chief Medical Off | G - Gift | $0.00 | -22.3K | 30.0K | -43% | $0 |
| D | 2022-09-02 | 2022-08-31 | OKUR | GREY MICHAEL G | Executive COB, Dir | M - OptEx | $1.97 | +50.0K | 50.0K | New | +$98.5K |
| I | 2022-09-02 | 2022-09-01 | OKUR | Cruse Michael | COO | P - Purchase | $3.39 | +7,500 | 13.7K | +121% | +$25.4K |
| M | 2022-08-31 | 2022-08-29+ | OKUR | Cruse Michael | COO | P - Purchase | $3.17 | +1,058 | 31.8K | +3% | +$3,350 |
| MI | 2022-08-31 | 2022-08-29+ | OKUR | Cruse Michael | COO | P - Purchase | $3.21 | +6,197 | 6,197 | New | +$19.9K |
| D | 2021-12-14 | 2021-12-10 | OKUR | FLESHER GREGORY J. | Pres, CEO, Dir | A - Grant | $0.00 | +100.0K | 109.6K | +1,042% | $0 |
| D | 2021-12-14 | 2021-12-10 | OKUR | Jindal Vineet R. | CFO | A - Grant | $0.00 | +30.0K | 36.6K | +455% | $0 |
| D | 2021-12-14 | 2021-12-10 | OKUR | Cruse Michael | Senior VP-Corp. Ops | A - Grant | $0.00 | +25.0K | 29.1K | +610% | $0 |
| D | 2021-12-14 | 2021-12-10 | OKUR | Dorenbaum Alejandro | Chief Medical Off | A - Grant | $0.00 | +30.0K | 52.3K | +134% | $0 |
| D | 2021-11-15 | 2021-11-12 | OKUR | Hall Ashley | Chief Development Off | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| 2021-08-26 | 2021-08-25 | OKUR | Jindal Vineet R. | CFO | P - Purchase | $7.44 | +5,000 | 5,000 | New | +$37.2K | |
| 2021-08-26 | 2021-08-25 | OKUR | FLESHER GREGORY J. | Pres, CEO, Dir | P - Purchase | $8.00 | +8,000 | 8,000 | New | +$64.0K | |
| 2021-08-26 | 2021-08-25 | OKUR | Cruse Michael | Senior VP-Corp. Ops | P - Purchase | $7.45 | +2,500 | 2,500 | New | +$18.6K | |
| 2021-07-15 | 2021-07-14 | OKUR | Johnson Wendy S. | Chief Development Off | S - Sale | $8.50 | -111.7K | 0 | -100% | -$949.8K | |
| I | 2021-07-15 | 2021-07-14 | OKUR | Muralidhar Bali | Dir | P - Purchase | $8.50 | +111.7K | 2.07M | +6% | +$949.8K |
| D | 2021-07-09 | 2021-07-08 | OKUR | Johnson Wendy S. | Chief Development Off | M - OptEx | $1.97 | +111.7K | 111.7K | New | +$220.1K |
Purchase Sale Sale after option exercise All abbreviations